Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
305 |
|
| Actual shortage: | 11 (4%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 5 (2%) | |
| Resolved: | 288 (94%) | |
Discontinuation Reports |
0 |
|
| To be discontinued: | 0 | |
| Discontinued: | 0 | |
| Reversed: | 0 | |
Late reports |
48 (16%) |
|
Overdue reports |
3 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-04-13 | 2022-05-01 | 158801 |
| SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-04-28 | 2022-05-24 | 159570 |
| SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-06-27 | 2022-08-21 | 163521 |
| SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-07-29 | 2022-08-21 | 165704 |
| SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-10-03 | 2023-02-09 | 170965 |
| SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-10-03 | 2022-12-05 | 170968 |
| SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2022-10-03 | 2023-02-09 | 170971 |
| SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Resolved | 2023-01-02 | 2023-01-26 | 179693 |
| SODIUM CHLORIDE INJECTION, USP | 234MG | SOLUTION | Actual shortage | 2024-03-06 | 2024-03-06 | 221460 |
| POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2017-05-10 | 2017-05-27 | 10000 |
| POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2021-10-01 | 2021-10-22 | 146596 |
| POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2022-04-13 | 2022-11-03 | 158777 |
| POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2022-04-13 | 2022-05-02 | 158780 |
| POTASSIUM PHOSPHATES INJECTION, USP | 236MG 224MG | SOLUTION | Resolved | 2022-04-26 | 2023-04-13 | 159355 |
| MANNITOL INJECTION, USP | 25% | SOLUTION | Resolved | 2022-06-08 | 2022-10-13 | 162159 |
| BIVALIRUDIN FOR INJECTION | 250MG | POWDER FOR SOLUTION | Resolved | 2021-11-24 | 2022-02-04 | 149848 |
| BIVALIRUDIN FOR INJECTION | 250MG | POWDER FOR SOLUTION | Resolved | 2022-10-02 | 2023-01-02 | 170875 |
| BIVALIRUDIN FOR INJECTION | 250MG | POWDER FOR SOLUTION | Resolved | 2023-08-03 | 2023-11-18 | 201032 |
| CEFTAZIDIME FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Resolved | 2021-12-10 | 2022-05-24 | 150950 |
| MITOXANTRONE INJECTION | 2MG | SOLUTION | Resolved | 2020-04-20 | 2020-05-06 | 112481 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0